Table 1.
Author, Yr (ref) | Sample size | Peak SCr, mg/dl | Final SCr, mg/dl | Follow-Up, Mo | Comment | |||
Steroid | No Steroid | Steroid | No Steroid | Steroid | No Steroid | |||
Clarkson et al. 2004 (4) | 26 | 16 | 7.9 | 6.1 | 1.6 | 1.6 | 12 | Patients received steroids late after diagnosis (median delay >3 wk). |
González et al. 2008 (5) | 52 | 9 | 5.9 | 4.9 | 2.1 | 3.7 | 19 | Steroid treated patients with complete recovery had shorter delay to steroids (13 d) as compared with those without complete recovery (34 d). |
Raza et al. 2012 (7) | 37 | 12 | 6.5 | 5.2 | 2.8 | 3.4 | 19 | Improved GFR with steroid versus control (P<0.05). No difference in kidney outcomes on the basis of steroid timing. |
Muriithi et al. 2014 (6) | 83 | 12 | 3.0 | 4.5 | 1.4 | 1.5 | 6 | Steroid-treated patients had superior kidney outcomes with early versus late steroid therapy. |
Valluri et al. 2015 (8) | 73 | 51 | 4.03 | 3.16 | NR | NR | 12 | Worse kidney function in steroid-treated versus control at biopsy (SCr 4.2 versus 3.3 mg/dl). Steroid-treated patients had complete recovery (48%) versus control group (41%); final SCr not different at 1 yr. |
Prendecki et al. 2016 (9) | 158 | 29 | 20.5 ml/min (eGFR) | 25 ml/min (eGFR) | 43 ml/min (eGFR) | 24 ml/min (eGFR) | 24 | Steroid-treated patient had better eGFR at 2 yr and less dialysis (5.1% versus 24.1%). Dose, duration, and time to steroid initiation were variable. |
SCr, serum creatinine concentration; NR, not reported.